Additionally, pancreatic cancer cells expressing SDC1 can interact with T cells expressing CCL5 in the TME, promoting tumor migration, and thereby providing a potential target for immunotherapy in pancreatic cancer (64). The gene discussed is CCL5; the disease is familial pancreatic carcinoma.